Zhang J A, Li J R, Qiao Y J
Emergency Department, Tianjin Hospital, Tianjin, China.
Intensive Care Unit, Tianjin People's Hospital, Tianjin, China.
Genet Mol Res. 2015 Aug 7;14(3):9163-70. doi: 10.4238/2015.August.7.26.
The aim of this study was to investigate the correlation between the A1166C polymorphism in the angiotensin II type 1 receptor (AT1R) gene and heart failure (HF) risk using meta‑analysis. The PubMed database was searched, and data were extracted independently by two reviewers. Odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used to assess the strength of the associations. Statistical analysis was performed using the STATA 12.0 software. The results of the meta‑analysis showed no significant association between the AT1R A1166C polymorphism and HF risk (AA vs CC: OR = 0.72, 95%CI = 0.31-1.68; AA vs AC: OR = 0.78, 95%CI = 0.52-1.18; dominant model: OR = 1.37, 95%CI = 0.92-2.04; recessive model: OR = 0.73, 95%CI = 0.30-1.75). In the subgroup analysis by ethnicity, the results also showed no significant association between A1166C polymorphism and susceptibility to HF in both Caucasian and Asian populations. In conclusion, this meta-analysis suggests that the A1166C polymorphism in AT1R may not be associated with susceptibility to HF. Further large and well-designed studies are needed to confirm these conclusions.
本研究旨在通过荟萃分析探讨血管紧张素II 1型受体(AT1R)基因中的A1166C多态性与心力衰竭(HF)风险之间的相关性。检索了PubMed数据库,由两名审阅者独立提取数据。使用比值比(OR)及其相应的95%置信区间(CI)来评估关联强度。使用STATA 12.0软件进行统计分析。荟萃分析结果显示,AT1R A1166C多态性与HF风险之间无显著关联(AA与CC比较:OR = 0.72,95%CI = 0.31 - 1.68;AA与AC比较:OR = 0.78,95%CI = 0.52 - 1.18;显性模型:OR = 1.37,95%CI = 0.92 - 2.04;隐性模型:OR = 0.73,95%CI = 0.30 - 1.75)。在按种族进行的亚组分析中,结果还显示,在白种人和亚洲人群中,A1166C多态性与HF易感性之间均无显著关联。总之,这项荟萃分析表明,AT1R中的A1166C多态性可能与HF易感性无关。需要进一步开展大规模且设计良好的研究来证实这些结论。